Development of heart organoid cryopreservation method through Fe3 O4 nanoparticles based nanowarming system

Biotechnol J. 2024 Jan;19(1):e2300311. doi: 10.1002/biot.202300311. Epub 2023 Dec 7.

Abstract

Beyond single cell two-dimensional (2D) culture, research on organoids that can mimic human organs is rapidly developing. However, there are still problems in commercialization and joint research using organoids due to the lack of technology to safely store organoids. Since organoids are 3D complex structures with a certain size (0.1-5 mm) beyond the size of cells, the conventional cell-level cryopreservation method using cryoprotectant (CPA) cannot overcome the damage caused by volume change due to osmotic pressure difference and ice nucleation. Herein, we attempted to solve such limitations by applying a nanowarming system using CPA with high cell permeability and Fe3 O4 nanoparticles. By performing beat rate measurement, histological analysis, contractility analysis, and multi-electrode array, it was verified that the developed method could significantly improve functional recovery and survival of heart organoids after freezing and thawing. In this study, we demonstrated a successful organoid cryopreservation method based on a Fe3 O4 nanowarming system. The developed technology will provide clues to the field of tissue cryopreservation and spur the application of organoids.

Keywords: cryopreservation; cryoprotectant; heart organoids; iron oxide nanoparticle; nanowarming.

MeSH terms

  • Cryopreservation* / methods
  • Cryoprotective Agents / pharmacology
  • Freezing
  • Humans
  • Nanoparticles*
  • Organoids

Substances

  • Cryoprotective Agents